• Disease-Modifying Therapies
    2026/04/29
    • Antisense oligonucleotide– zorevunersen
    • Histamine antagonist– clemizole hydrochloride
    • Serotonin agonist– bexicaserin
    • Gene therapy– ETX101

    続きを読む 一部表示
    13 分
  • Optimizing Standards of Care
    2026/04/29
    • Seizure management–cannabidiol, fenfluramine, stiripentol; ketogenic diet
    • Multidisciplinary care
    • Dravet Syndrome Foundation Transition Guide
    • Seizure action plan

    続きを読む 一部表示
    20 分
  • Improving Diagnosis
    2026/04/29
    • Key features and triggers
    • Imaging
    • DS mimics
    • Genetic testing

    続きを読む 一部表示
    8 分
  • Developmental and Epileptic Encephalopathy
    2026/04/29
    • Description and course
    • Comorbidities
    • SCN1A gene mutation
    • Disease burden
    続きを読む 一部表示
    14 分